E. F. Desgranges-b, Concepts et modèles en neuropsychologie de la mémoire : entre théorie et pratique clinique, 2003.

E. F. Lechevalier-b and . Viader-f, La mémoire : Neuropsychologie clinique et modèles cognitifs, 1996.

E. F. Curran-h and L. M. Shine-p, The effects on memory of pipequaline, alone or in combination with diazepam, Psychopharmacology, vol.95, issue.3, pp.386-389, 1988.

F. J. Forsell-y, Benzodiazepines may have protective effects against Alzheimer disease, Alzheimer Dis Assoc Disord, vol.12, issue.1, pp.14-17, 1998.

F. M. Mcmahon-a, Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?, Ann Intern Med, vol.132, issue.2, pp.134-143, 2000.

F. C. and M. C. Gimenez-f, Clinical pharmacokinetics of zopiclone, Clinical Pharmacokinetics, vol.29, issue.6, pp.431-441, 1995.

F. J. Vorhees-c, Developmental toxicity of antiepileptic drugs: relationship to postnatal dysfunction, Pharmacol Res, vol.26, issue.3, pp.207-221, 1992.

F. J. Staley-b, AED Treatment Through Different Ages: As Our Brains Change, Should Our Drug Choices Also?, Epilepsy Curr, vol.12, pp.22-27, 2012.

G. L. Polimeni-g, E. Salvo-f, and . Al, Short-term memory loss associated with rosuvastatin, Pharmacotherapy, vol.26, issue.8, pp.1190-1192, 2006.

G. J. , E. P. , P. J. Et, and . Al, Benzodiazepine use and risk of dementia: evidence from Caerphilly Prospective Study (CaPS), J Epidemiol Community Health, vol.66, issue.10, pp.869-873, 2012.

I. Bureau and . Epilepsy, Cognitive function survey -New survey reveals devastating impact of some epilepsy drugs on normal brain function. Disponible sur http, 2004.

S. M. Ito-m, T. , and P. , Climbing fibre induced depression of both mossy fibre responsiveness and glutamate sensitivity of cerebellar Purkinje cells, The Journal of Physiology, vol.324, issue.1, pp.113-134, 1982.
DOI : 10.1113/jphysiol.1982.sp014103

J. W. and M. M. Ochs-m, Functional Reorganization of Primary Somatosensory Cortex in Adult Owl Monkeys After Behaviorally Controlled Tactile Stimulation, J Neurophysiol, vol.63, issue.1, pp.82-104, 1990.

J. D. , S. J. Hwang-y, and E. Al, Dexibuprofen (S(+)-isomer ibuprofen) reduces microglial activation and impairments of spatial working memory induced by chronic lipopolysaccharide infusion, Pharmacol Biochem Behav, vol.89, issue.3, pp.404-411, 2008.

J. R. Keshavan-m, Classifying antipsychotic agents: need for new terminology, CNS Drugs, vol.22, issue.12, pp.1047-1059, 2008.

K. S. Tookman-a and C. H. Jones-l, The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care

K. G. Crook-t and R. L. , Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects, Eur Urol, vol.50, issue.2, pp.317-326, 2006.

L. B. Eustache-f and . Viader-f, Traité de neuropsychologie clinique, 2008.

L. F. Vidailhet-p and D. J. , Time course of the effects of diazepam and lorazepam on perceptual priming and explicit memory, Psychopharmacology, vol.118, issue.4, pp.475-479, 1995.

L. De-recherche, Évolution comparée des ventes de médicaments dans 7 pays européens Disponible sur http, 2000.

L. M. Uusvaara-j and L. J. , Anticholinergic drugs and their effects on delirium and mortality in the elderly, Dement Geriatr Cogn Dis Extra, vol.1, issue.1, pp.43-50, 2011.

L. C. and B. J. Green-r, Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial, Neurology, vol.68, issue.21, pp.1800-1808, 2007.

M. A. Brembilla-perrot and . Hanesse-b, Troubles cognitifs chez les sujets de plus de 65 ans induits par la prise de digoxine, Ann Cardiol Angeiol, vol.55, issue.5, pp.246-248, 2006.

M. L. Moran-c and . Namjoshi-o, Cognition-impairing effects of benzodiazepine-type drugs: Role of GABAA receptor2 subtypes in an executive function task in rhesus monkeys, Pharmacol Biochem Behav, vol.104, issue.1, pp.1-7, 2013.

M. R. Kitazawa-m and C. A. , Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline, Am J Pathol, vol.179, issue.2, pp.981-991, 2011.

M. G. Galanter-e and P. K. , Plans and the structures of behavior, 1960.

M. M. Griffiths-r, Triazolam and zolpidem: effects on human memory and attentional processes, Psychopharmacology, vol.144, issue.1, pp.8-19, 1999.

M. M. Stitzer-m, Cognitive impairment in methadone maintenance patients, Drug Alcohol Depend, vol.67, issue.1, pp.41-51, 2002.

M. M. Wezenberg-e and . J. Verkes-r, Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short-term administration, J Clin Psychopharmacol, vol.27, issue.1, pp.15-21, 2007.

M. C. and B. J. Franks-j, Levels of processing versus transfer appropriate processing, J. Verb. Learn. Verb. Behav, vol.16, issue.1, pp.519-533, 1977.

M. G. Meador-k, Antiepileptic drugs and memory, Epilepsy Behav, vol.5, issue.4, pp.435-439, 2004.

M. M. Trimble-m, Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors, CNS Drugs, vol.23, issue.2, pp.121-137, 2009.

N. E. Gupta-k and C. J. , Cholinergic modulation of cognitive processing: insights drawn from computational models, Front Behav Neurosci, vol.6, issue.24, pp.1-19, 2012.

N. D. Shallice-t, Attention to action: Willed and automatic control of behavior, Consciousness and selfregulation: Advances in research and theory, pp.1-18, 1986.

N. D. Stahl-s, Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics, J Psychopharmacol, vol.24, issue.11, pp.1601-1612, 2010.

O. and G. C. Dinan-t, Executive function in schizophrenia: what impact do antipsychotics have?, Hum Psychopharmacol, vol.22, issue.6, pp.397-406, 2007.

O. J. El and L. J. Spadone-c, Résultats d'une enquête sur l'usage des antidépresseurs en population générale française, Encéphale, vol.28, issue.5, pp.411-417, 2002.

O. P. Meador-k, Abstract:, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, vol.1977, issue.S3, pp.60-65, 2004.
DOI : 10.1111/j.1528-1157.1982.tb05439.x

P. K. Padala-p and P. J. , Simvastatin-Induced Decline in Cognition, Annals of Pharmacotherapy, vol.6, issue.10, pp.1880-1883, 2006.
DOI : 10.1016/S0162-3109(00)00272-1

P. A. Csapo-k, Concrete image and verbal memory codes, J Exp Psychol, vol.80, issue.2, pp.279-285, 1969.

P. A. Csapo-k, Picture superiority in free recall: imagery or dual coding?, Cognitive Psychology, vol.5, issue.3, pp.176-206, 1973.

P. E. Hamon-m, Hippocampal Neurogenesis, Depressive Disorders, and Antidepressant Therapy, Neural Plast, pp.1-7, 2007.

P. B. Gundersen-h, Neocortical neuron number in humans : effect of sex and age, J Comp Neurol, vol.384, issue.2, pp.312-320, 1997.

R. T. Merlotti-l and R. Zorick-f, Sedative, memory, and performance effects of hypnotics, Psychopharmacology, vol.116, issue.2, pp.130-134, 1994.

R. T. and R. T. Wittig-r, Benzodiazepines and memory, Br J Clin Pharmacol, vol.18, issue.1, pp.45-49, 1984.

S. G. Simons-m, Cholesterol and myelin biogenesis, Subcell Biochem, vol.51, issue.1, pp.489-508, 2010.

S. K. and K. K. Obrietan-k, CREB: a multifaced regulator of neuronal plasticity and protection, J Neurochem, vol.116, issue.1, pp.1-9, 2011.

S. T. Babcock-r, Decomposing adult age differences in working memory, Developmental Psychology, vol.27, issue.5, pp.763-776, 1991.

S. T. Kersten-a, Decomposing adult age differences in symbol arithmetic, Mem Cognit, vol.21, issue.5, pp.699-710, 1993.

S. T. Meinz-e, Aging, inhibition, working memory, and speed, J Gerontol B Psychol Sci Soc Sci, vol.50, issue.6, pp.297-306, 1995.

S. R. Gabaa, Receptor Physiology and Its Relationship to the Mechanism of Action of the 1,5-Benzodiazepine Clobazam, CNS Drugs, vol.26, issue.3, pp.229-244, 2012.

S. E. Busonero-f and . Talani-g, Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes, Eur J Pharmacol, vol.451, issue.2, pp.130-110, 2002.

S. S. Sandstrom-d and . A. Hoeffer-c, AP-1 functions upstream of CREB to control synaptic plasticity in Drosophila, Nature, vol.416, pp.870-874, 2002.

S. K. Sotiriou-e and . Papatheodoropoulos-c, Differential pharmacological properties of GABAA/benzodiazepine receptor complex in dorsal compared to ventral rat hippocampus, Neurochem Int, vol.52, issue.6, pp.1019-1029, 2008.

S. M. , O. D. Ugresi?-n, and . R. Bokonji?-d, Memory effects of benzodiazepines: Memory stages and types versus binding-site subtypes, Neural Plast, vol.12, issue.4, pp.289-298, 2005.

S. M. and O. D. Ugresi?-n, Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt, Psychopharmacology (Berl), vol.180, issue.3, pp.455-465, 2005.

S. M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update, Fundam Clin Pharmacol, vol.19, issue.1, pp.117-125, 2005.

S. F. Leuba-g and . Büla-c, Du vieillissement cérébral à la maladie d'Alzheimer, 2004.

S. L. Barnes-c, Neural protein synthesis during aging: Effects on plasticity and memory, Front Aging Neurosci, issue.2, pp.1-16, 2010.

S. S. Setoguchi-s and . Brookhart-a, Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients, CMAJ, vol.176, issue.5, pp.627-632, 2007.

S. L. Dagerman-k, Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials, JAMA, vol.294, issue.15, pp.1934-1943, 2005.

S. W. Milner-b, Loss of recent memory after bilateral hippocampal lesions, J Neurol Neurosurg Psychiat, vol.20, issue.1, pp.11-21, 1957.

S. F. and D. J. Kauffmann-muller-f, Differential effects of diazepam and lorazepam on repetition priming in healthy volunteers, Psychopharmacology, vol.108, issue.3, pp.371-379, 1992.

S. T. Warrington-e, Independent functioning of verbal memory stores : A neuropsychological study, Q J Exp Psychol, vol.22, issue.2, pp.261-273, 1970.

S. E. Steinmann-m, Structure, function, and modulation of GABA(A) receptors, J Biol Chem, vol.287, issue.48, pp.40224-40231, 2012.

T. J. Kokshoorn-n and . R. Biermasz-n, Subtle cognitive impairments in patients with long-term cure of Cushing's disease, J Clin Endocrinol Metab, vol.95, issue.6, pp.2699-2714, 2010.

T. T. Nifosi-f and F. H. , Volumetric MRI analysis of hippocampal subregions in Cushing's disease: A model for glucocorticoid neural modulation, Eur Psychiatry, vol.26, issue.1, pp.64-67, 2011.

T. M. , C. A. Boutouaba-combe, and . Verdoux-h, Étude sur la durée des traitements antidépresseurs en France et ses déterminants à partir des bases de données de l'Assurance maladie. L'Encéphale, pp.36-41, 2011.

T. M. Da-pozzo-e and D. S. , The GABAA-BZR complex as target for the development of anxiolytic drugs, Curr Top Med Chem, vol.12, issue.4, pp.254-269, 2012.

V. Tourtauchaux-r and . Galland-f, Les neuroleptiques dans une unité de psychiatrie pour sujets âgés de plus de 60 ans : étude de leur prescription, règles de bon usage, Ann Med Psychol, vol.165, issue.9, pp.664-670, 2007.

V. E. Crespo-i, S. A. , and W. S. , Clinical consequences of Cushing's syndrome, Pituitary, vol.15, issue.3, pp.319-329, 2012.

V. T. Schorn-h and . B. Vernaleken-i, Effects of antipsychotic treatment on cognition in healthy subjects, J Psychopharmacol, vol.27, issue.4, pp.374-385, 2013.

V. P. , D. J. Kauffmann-muller-f, and A. Et, Lorazepam and diazepam effects on memory acquisition in priming tasks, Psychopharmacology, vol.115, issue.3, pp.397-406, 1994.

V. S. Miller-d and F. W. Kowall-n, Protective effects of NSAIDs on the development of Alzheimer disease, Neurology, vol.70, pp.1672-1677, 2008.

W. L. Mitton-m and A. B. Doraiswamy-p, Statin-associated memory loss: analysis of 60 case reports and review of the literature, Pharmacotherapy, vol.23, issue.7, pp.871-880, 2003.

W. M. Gamo-n and Y. Y. , Neuronal basis of age-related working memory decline, Nature, vol.476, issue.7359, pp.210-213, 2011.

W. H. and H. D. Lister-r, Selective effects of triazolam on memory, Psychopharmacology, vol.106, issue.3, pp.341-345, 1992.

W. H. Rawlings-r and G. D. , Triazolam-induced changes in alcoholic thought processes, Psychopharmacology, vol.138, pp.3-4311, 1998.

W. H. Sirocco-k and . Rawlings-r, Dissociations in the expression of the sedative effects of triazolam, Psychopharmacology, vol.119, issue.1, pp.27-33, 1995.

W. J. Katz-j, Benzodiazepines: use, abuse, and consequences, Pharmacol Rev, vol.44, issue.2, pp.151-347, 1992.

W. C. Ting-t and W. S. , Effects of benzodiazepine discontinuation on dementia risk, Am J Geriatr Psychiatry, vol.19, issue.2, pp.151-159, 2011.

X. M. Liu-r, E. J. Et, and A. , Changes in the axonal conduction velocity of pyramidal tract neurons in the aged cat, Neuroscience, vol.92, issue.1, pp.219-225, 1999.

Y. J. , W. J. , and D. M. Vecchio, Induction of a dominant negative CREB transgene specifically blocks long-term memory in Drosophila, Cell, vol.79, issue.1, pp.49-58, 1994.

Y. X. Salter-m, Gain control of NMDA-receptor currents by intracellular sodium, Nature, vol.396, issue.6710, pp.469-474, 1998.

Z. K. and P. C. Sanday-l, Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task, Psychopharmacology (Berl), vol.226, issue.3, pp.459-474, 2013.